Skip to content
10-K

Annual Report

FINCH THERAPEUTICS GROUP, INC.

0000950170-24-035952

← back to feed
Filed
Mar 25, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 20, 2024 1.61M sh
Shares Diluted FY 2023 · Dec 31, 2023 1.6M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 1.59M sh
Capex FY 2023 · Dec 31, 2023 $0
Capex FY 2023 · Dec 31, 2022 $2.18M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$31.51M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$74.85M
Long Term Debt FY 2023 · Dec 31, 2023 $0
Long Term Debt FY 2023 · Dec 31, 2022 $14.65M
Cash And Equivalents FY 2023 · Dec 31, 2023 $25.12M
Cash And Equivalents FY 2023 · Dec 31, 2022 $71.04M
Stockholders Equity FY 2023 · Dec 31, 2023 $22.89M
Stockholders Equity FY 2023 · Dec 31, 2022 $95.71M
Stockholders Equity FY 2023 · Dec 31, 2021 $202.22M
Current Liabilities FY 2023 · Dec 31, 2023 $4.08M
Current Liabilities FY 2023 · Dec 31, 2022 $14.69M
Total Liabilities FY 2023 · Dec 31, 2023 $32.49M
Total Liabilities FY 2023 · Dec 31, 2022 $67.23M
Current Assets FY 2023 · Dec 31, 2023 $25.85M
Current Assets FY 2023 · Dec 31, 2022 $74.55M
Total Assets FY 2023 · Dec 31, 2023 $55.37M
Total Assets FY 2023 · Dec 31, 2022 $162.94M
Eps Diluted FY 2023 · Dec 31, 2023 −$46.59
Eps Diluted restated FY 2023 · Dec 31, 2022 −$72.12
Eps Basic FY 2023 · Dec 31, 2023 −$46.59
Eps Basic restated FY 2023 · Dec 31, 2022 −$72.12
Sga Expense FY 2023 · Dec 31, 2023 $26.91M
Sga Expense restated FY 2023 · Dec 31, 2022 $36.19M
Rd Expense FY 2023 · Dec 31, 2023 $7.2M
Rd Expense restated FY 2023 · Dec 31, 2022 $52.86M
Net Income FY 2023 · Dec 31, 2023 −$74.75M
Net Income FY 2023 · Dec 31, 2022 −$114.65M
Operating Income FY 2023 · Dec 31, 2023 −$83.86M
Operating Income FY 2023 · Dec 31, 2022 −$115.59M
Revenue FY 2023 · Dec 31, 2023 $107K
Revenue FY 2023 · Dec 31, 2022 $861K